ArticleInternal medicine (Tokyo, Japan)2026

The Efficacy and Safety of Atezolizumab Plus Bevacizumab after Durvalumab Plus Tremelimumab for the Treatment of Hepatocellular Carcinoma.

Shinsuke Uchikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.